Macorel (Nifedipine)

Nifedipine blocks L‑type calcium channels in the smooth muscle of blood vessels and the heart. By preventing calcium entry, it relaxes arterial walls, reduces peripheral resistance, and lowers blood pressure while also decreasing the heart's oxygen demand, helping to control angina.

The appropriate dose of Macorel is determined by the prescribing clinician based on the individual’s medical condition, response to therapy, and any concurrent medications. Dosage adjustments are made during follow‑up visits to achieve optimal blood‑pressure control or angina relief.

Safety data for nifedipine in pregnancy and lactation are limited. The medication should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To request Macorel, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with other antihypertensives, nifedipine offers rapid vasodilation and is effective for both hypertension and angina. Unlike beta‑blockers, it does not reduce heart rate, and unlike ACE inhibitors, it works directly on vascular smooth muscle. Choice of therapy depends on patient‑specific factors and comorbidities.

Macorel should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiry date printed on the label.

Macorel is taken orally, usually with a glass of water. It may be taken with or without food, but patients should follow the prescribing physician’s instructions regarding timing and whether the dose should be taken on an empty stomach.

Serious risks include severe hypotension, myocardial infarction, life‑threatening arrhythmias, and allergic reactions such as rash or angioedema. Patients should seek immediate medical attention if they experience fainting, chest pain, rapid heartbeat, or signs of an allergic response.

Macorel is contraindicated in patients with known hypersensitivity to nifedipine or other dihydropyridine calcium channel blockers, and in those with severe aortic stenosis or uncontrolled heart failure. Clinicians must evaluate each patient’s medical history before prescribing.